Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2019-10-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
备考审计报告及财务报告表（2018年度-2019年7月）
Regulatory Filings
2019-10-11 Chinese
未来三年（2019年-2021年）股东回报规划
Regulatory Filings Classification · 85% confidence The document is titled as a "Future Three-Year (2019-2021) Shareholder Return Plan" issued by the board of Zhejiang Huatong Pharmaceutical Co., Ltd. It discusses the company's dividend policy, profit distribution principles, and shareholder return planning over a multi-year period. The content focuses on the company's planned approach to dividends and shareholder returns rather than announcing a specific dividend payment or amount. It is a detailed policy or plan document rather than a simple announcement of dividend amounts or payment dates. The document length is 2141 characters, which is relatively short but contains substantive content about the dividend policy and planning. It is not a dividend amount notice (DIV) because it does not specify dividend amounts or payment dates. It is not a report publication announcement (RPA) or regulatory filing (RNS) because it contains the actual policy content, not just a notice. The document fits best under the category of a formal shareholder return or dividend policy plan, which aligns most closely with the Notice of Dividend Amount (DIV) category in the absence of a more specific category for dividend policy plans. However, since DIV is typically for announcements of dividend amounts and payment details, and this document is a multi-year shareholder return plan, the best fit is Regulatory Filings (RNS) as a fallback category for regulatory announcements that do not fit other categories exactly.
2019-10-11 Chinese
2019年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2019 first extraordinary general meeting (临时股东大会) of Zhejiang Huatong Pharmaceutical Co., Ltd. It includes voting results for various board and supervisory board elections and other shareholder proposals. The document contains specific voting outcomes and legal opinions confirming the validity of the meeting and its resolutions. It is not a full annual or interim report, nor a management discussion or earnings release. It is not a proxy solicitation or a report publication announcement. The content clearly matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the results of shareholder votes at a general meeting.
2019-10-11 Chinese
审计报告及财务报表（2018年1月1日至2019年7月31日）
Regulatory Filings
2019-10-11 Chinese
2019年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, qualifications of attendees, voting procedures, and results of the 2019 first extraordinary general meeting (临时股东大会) of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the legality and validity of the meeting process and voting outcomes, including election of board members and other resolutions. The document does not contain financial statements or management discussion of financial results, nor is it a simple announcement of a meeting or voting results. Instead, it is a legal opinion on the meeting and voting process. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides official results and legal validation of shareholder votes at a general meeting.
2019-10-11 Chinese
独立董事关于公司第四届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Zhejiang Huatong Pharmaceutical Co., Ltd. regarding matters discussed at the first meeting of the fourth board of directors. It includes opinions on the appointment of senior management and the company's three-year shareholder return plan. The document references compliance with company law, stock exchange listing rules, and regulatory guidelines, but it is not a full financial report or earnings release. It is a formal board/management related announcement about governance and management decisions rather than a report containing financial data or audit results. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management appointments and opinions, not a full report or announcement of voting results or proxy materials.
2019-10-11 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.